Subscribe to our Newsletters !!
Few developments in science and technology have be
The pharmaceutical sector is experiencing revoluti
The recent rabies death of an 11 year old Canadian
Alembic Pharmaceutica
Generic medicines have become a cornerstone in hea
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to the latest issue of Mi
The journey from identifying a potential drug candidate to delivering a safe, effective therapy is long and complex. It involves multiple stages of screening, optimization, and validation—each demanding accuracy, speed, and informed decision-making. At the center of this process are medicinal chemists, whose work transforms early-stage molecules into viable drug candidates.
Modern drug discovery has moved far beyond studying one compound at a time. Today, researchers screen large numbers of molecules in parallel, sourced from natural, synthetic, or biological origins. This shift has made rapid and reliable characterization essential.
Early-stage decisions, driven by high-quality analytical data, play a crucial role in avoiding costly failures later in development.
Medicinal chemists typically work with small-scale experiments to identify promising lead molecules.
To do this effectively, they rely on a combination of advanced tools—ranging from sample preparation systems and flexible synthesis platforms to precise analytical techniques. These technologies help accelerate workflows while ensuring consistent and reproducible results.
As compounds move into development, the focus shifts to optimizing synthesis processes. Chemists must balance performance, safety, and cost, particularly when scaling up reactions. Technologies such as automated laboratory reactors, combined with Design of Experiments (DoE) and Process Analytical Technology (PAT), offer valuable insights into reaction behavior and help streamline process optimization.
Real-time analytical tools are also transforming chemical development. Techniques like FTIR and Raman spectroscopy, along with in-line particle size analysis, allow scientists to monitor reaction kinetics, pH, dissolved gases, and particle formation as processes unfold.
When paired with complementary offline methods—such as UV-Vis spectroscopy, thermal analysis, and melting point determination—this integrated approach provides a deeper understanding of both compounds and processes.
Equally important is ensuring compliance in a highly regulated industry. Integrated instrument and software solutions enable data traceability, support regulatory requirements such as FDA 21 CFR Part 11, and simplify the transition from laboratory research to production.
In an environment where time, quality, and compliance are critical, advanced analytical technologies empower medicinal chemists to make faster, more confident decisions. Ultimately, they help the pharmaceutical industry bring innovative therapies to market more efficiently benefiting both researchers and patients alike.
METTLER TOLEDO is a leading global manufacturer of precision instruments. The Company is the world’s largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The Company also holds top-three market positions for several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world’s largest manufacturer and marketer of metal detection systems used in production and packaging. Additional information about
METTLER TOLEDO is available at www.mt.com.
Visit us: https://www.mt.com/in/en/home/industries/standard-drugs-and-pharmaceuticals-molecules/chemical-based-drug-discovery-and-development.html
Email us at – [email protected]
Call us toll-free at – 1800 22 8884 & 1800 1028 460
